These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease. Shukla S, Agrawal AK, Chaturvedi RK, Seth K, Srivastava N, Sinha C, Shukla Y, Khanna VK, Seth PK. J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661 [Abstract] [Full Text] [Related]
13. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease. Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T. Neuroscience; 2014 Jan 31; 258():385-400. PubMed ID: 24291725 [Abstract] [Full Text] [Related]
14. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action. Voutilainen MH, De Lorenzo F, Stepanova P, Bäck S, Yu LY, Lindholm P, Pörsti E, Saarma M, Männistö PT, Tuominen RK. eNeuro; 2017 Jan 31; 4(1):. PubMed ID: 28303260 [Abstract] [Full Text] [Related]
15. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Apostolides C, Sanford E, Hong M, Mendez I. Neuroscience; 1998 Mar 31; 83(2):363-72. PubMed ID: 9460746 [Abstract] [Full Text] [Related]
16. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease. Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL. Neuroscience; 2014 Aug 22; 274():11-23. PubMed ID: 24845869 [Abstract] [Full Text] [Related]
17. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway. Yue P, Gao L, Wang X, Ding X, Teng J. Neurochem Res; 2017 May 22; 42(5):1366-1374. PubMed ID: 28247332 [Abstract] [Full Text] [Related]
18. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR. Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387 [Abstract] [Full Text] [Related]
19. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Wang Y, Tien LT, Lapchak PA, Hoffer BJ. Cell Tissue Res; 1996 Nov 18; 286(2):225-33. PubMed ID: 8854891 [Abstract] [Full Text] [Related]
20. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Sullivan AM, Opacka-Juffry J, Blunt SB. Eur J Neurosci; 1998 Jan 18; 10(1):57-63. PubMed ID: 9753113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]